IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2023

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Endurant Capital Management LP 80,455$491,5800.25%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,831,607$11,191,1190.25%
Intellectus Partners, LLC 108,879$665,2480.21%
QVT Financial LP 678,564$4,146,0260.20%
Nikko Asset Management Americas, Inc. 2,548,991$15,446,8850.18%
Point72 Asset Management, L.P. 8,800,059$53,768,3600.17%
J. Goldman & Co LP 651,664$3,981,6670.16%
Bridgefront Capital, LLC 38,528$235,4060.14%
GSA CAPITAL PARTNERS LLP 216,782$1,3250.13%
Newtyn Management, LLC 105,000$641,5500.13%
DUALITY ADVISERS, LP 181,738$1,110,4190.13%
ALGERT GLOBAL LLC 415,013$2,5360.12%
C WorldWide Group Holding A/S 1,360,000$8,3100.11%
CARLSON CAPITAL L P 182,109$1,112,6860.10%
J. Goldman & Co LP 405,000$2,474,5500.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 56,000$341,6000.10%
HARBOR CAPITAL ADVISORS, INC. 51,169$312,6430.09%
Brevan Howard Capital Management LP 534,170$3,263,7790.09%
PROFUND ADVISORS LLC 202,037$1,234,4460.08%
SEVEN EIGHT CAPITAL, LP 58,924$360,0260.08%
External links

This page lists IOVANCE BIOTHERAPEUTICS INC's shareholders in Q1 2023. To view IOVANCE BIOTHERAPEUTICS INC's shareholder history, click here.